http://www.fda.gov/cder/drug/infopage/elidel/default.htm
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
The FDA has issued a public health advisory to inform healthcare professionals and patients about a potential cancer risk from use of Elidel (pimecrolimus).